Emerging Business Models for Biotechnology Firms and Clusters: Policy Responses in Peripheral Regions of the EU

Ewen Peters and Stephen Young

Chapter 8 in Multinationals, Clusters and Innovation, 2006, pp 120-141 from Palgrave Macmillan

Abstract: Abstract The aim of this chapter is to identify the emerging policy challenges1 facing the governments of peripheral regions in Europe where biotechnology has been targeted as a growth sector. Specifically, the research question is whether it is advisable or feasible for peripheral areas to target this sector, where financial demands and risks (but also potential returns) are high. In answering this question, the relevance of clusters and innovative milieux2 to the biotechnology sector is examined in the light of the new post-genomic business models that are emerging.

Keywords: Business Model; Drug Discovery; Venture Capital; Market Failure; Initial Public Offering (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-62494-8_8

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230624948

DOI: 10.1057/9780230624948_8

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().